Rockwell Deferred Long Term Liab from 2010 to 2024
| RMTI Stock | USD 2.31 0.06 2.67% |
Deferred Long Term Liabilities | First Reported 2011-06-30 | Previous Quarter 0.0 | Current Value 0.0 | Quarterly Volatility 9.5 M |
Check Rockwell Medical financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Rockwell Medical's main balance sheet or income statement drivers, such as Depreciation And Amortization of 1 M, Interest Expense of 2.2 M or Total Revenue of 45.6 M, as well as many indicators such as Price To Sales Ratio of 0.5, Dividend Yield of 0.0 or PTB Ratio of 1.97. Rockwell financial statements analysis is a perfect complement when working with Rockwell Medical Valuation or Volatility modules.
Rockwell | Deferred Long Term Liab |
Latest Rockwell Medical's Deferred Long Term Liab Growth Pattern
Below is the plot of the Deferred Long Term Liab of Rockwell Medical over the last few years. It is liabilities that are due after more than one year, including deferred tax liabilities and deferred revenue. Rockwell Medical's Deferred Long Term Liabilities historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Rockwell Medical's overall financial position and show how it may be relating to other accounts over time.
| Deferred Long Term Liab | 10 Years Trend |
|
Deferred Long Term Liab |
| Timeline |
Rockwell Deferred Long Term Liab Regression Statistics
| Arithmetic Mean | 12,540,325 | |
| Geometric Mean | 0.00 | |
| Coefficient Of Variation | 64.23 | |
| Mean Deviation | 6,816,478 | |
| Median | 16,723,318 | |
| Standard Deviation | 8,054,289 | |
| Sample Variance | 64.9T | |
| Range | 20.1M | |
| R-Value | 0.66 | |
| Mean Square Error | 39.2T | |
| R-Squared | 0.44 | |
| Significance | 0.01 | |
| Slope | 1,192,628 | |
| Total Sum of Squares | 908.2T |
Rockwell Deferred Long Term Liab History
About Rockwell Medical Financial Statements
Investors use fundamental indicators, such as Rockwell Medical's Deferred Long Term Liab, to determine how well the company is positioned to perform in the future. Although Rockwell Medical's investors may analyze each financial statement separately, they are all interrelated. Understanding these patterns can help investors make the right trading decisions.
| Last Reported | Projected for Next Year | ||
| Deferred Long Term Liabilities | 19.2 M | 11.6 M |
Currently Active Assets on Macroaxis
When determining whether Rockwell Medical offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Rockwell Medical's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Rockwell Medical Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Rockwell Medical Stock:Check out the analysis of Rockwell Medical Correlation against competitors. For more detail on how to invest in Rockwell Stock please use our How to Invest in Rockwell Medical guide.You can also try the Equity Forecasting module to use basic forecasting models to generate price predictions and determine price momentum.
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Rockwell Medical. If investors know Rockwell will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Rockwell Medical listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (0.04) | Revenue Per Share 3.041 | Quarterly Revenue Growth 0.429 | Return On Assets (0.04) | Return On Equity (0.29) |
The market value of Rockwell Medical is measured differently than its book value, which is the value of Rockwell that is recorded on the company's balance sheet. Investors also form their own opinion of Rockwell Medical's value that differs from its market value or its book value, called intrinsic value, which is Rockwell Medical's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Rockwell Medical's market value can be influenced by many factors that don't directly affect Rockwell Medical's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Rockwell Medical's value and its price as these two are different measures arrived at by different means. Investors typically determine if Rockwell Medical is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Rockwell Medical's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.